Clinical Trials Directory

Trials / Completed

CompletedNCT04376281

The Effect of Norepinephrine on Cardiac Output in Patients Undergoing Liver Transplant .

The Effect of Norepinephrine on Blood Volume Cardiac , Output and Systemic Filling Pressure in Patients Undergoing Liver Transplant .

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Early administration of NE in liver transplant recipient might enhance cardiac output through an increase in cardiac preload .

Detailed description

The derangement of circulatory blood volume in patients with liver cirrhosis makes intraoperative fluid management during liver transplant is challenging . Cirrhotic patients not only have large blood volume but abnormal blood volume distribution, with a substantial fraction of this volume in the splanchnic circulation (. These hemodynamic changes render volume loading in these patients has little impact on CO because a large proportion of infused fluid is shifted to the splanchnic system . In addition, patients with liver cirrhosis is similar to septic patients who have increased total vascular compliance which may cause pooling of blood in venous pool. Several studies in patients with sepsis found that use of low dose vasopressor may convert unstressed blood volume (i.e the amount of blood not causing pressure on the vessels) to stressed volume (i.e additional blood causing a distending pressure on the vascular walls and reflects the effective circulating volume) . However, no previous studies tested the effect of using norepinephrine (NE) on venous return and cardiac preload in patients undergoing liver transplant. An obvious advantage of this possibility is that NE will be used instead of true fluid replacement which may minimize fluid replacement during operation. Recently, a method was described to estimate the changes in intravascular volume and vascular capacitance by calculating mean systemic filling pressure (MSFP) . MSFP is the driving pressure in venous return, and it allows calculation of the arterial and venous components of systemic vascular resistance .

Conditions

Interventions

TypeNameDescription
DRUGNoradrenalineNoradrenaline infusion for patients undergoing liver transplantaion from living donor .

Timeline

Start date
2019-12-15
Primary completion
2021-08-01
Completion
2021-10-01
First posted
2020-05-06
Last updated
2021-11-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04376281. Inclusion in this directory is not an endorsement.